Archive for December 11th, 2009

New York Times Highlights Steroid Use in IFBB Pro Bodybuilding
by Millard Baker

The New York Times highlighted the widespread use of steroids in competitive bodybuilding suggesting that anabolic steroids cause a specific form of kidney disease known as focal segmental glomerulosclerosis. This was the disease that required IFBB pro bodybuilder Flex Wheeler to undergo kidney transplant surgery. The article interviews three IFBB pro bodybuilders: Flex Wheeler, King Kamali, and Bob Cicherillo.

The study in the Journal of the American Society of Nephrology allegedly establishes a direct link between steroid use and kidney damage (”Bodybuilders See Kidney Damage with Steroids,” December 10).
Read the rest of this entry »

Slate Pharmaceuticals Supports Testosterone Replacement Therapy for Pro Athletes
by Millard Baker

Robert Whitehead, the President and CEO of Slate Pharmaceuticals, released a statement defending the use of the anabolic steroid testosterone by professional athletes when prescribed by a physician to treat low testosterone levels. Slate is the manufacturer of Testogel testosterone pellets. The statement is noteworthy because it represents the first time big pharma has been bold enough to criticize the anti-doping policies in professional sports.
Read the rest of this entry »